BioCardia (BCDA) News Today $2.99 +0.04 (+1.36%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 8:11 AM | stockhouse.comPatient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart FailureJuly 17, 2024 | globenewswire.comBioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal ApplicationJune 7, 2024 | globenewswire.comBioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery ApproachMay 22, 2024 | finanznachrichten.deBioCardia, Inc.: BioCardia Announces Reverse Stock SplitMay 21, 2024 | globenewswire.comBioCardia Announces Reverse Stock SplitMay 18, 2024 | finance.yahoo.comBioCardia, Inc. (BCDA)May 15, 2024 | finanznachrichten.deBioCardia, Inc.: BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsMay 15, 2024 | finance.yahoo.comBioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...May 14, 2024 | investorplace.comBCDA Stock Earnings: BioCardia Reported Results for Q1 2024May 14, 2024 | globenewswire.comBioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsMay 14, 2024 | finance.yahoo.comMost Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is ReasonableMay 9, 2024 | globenewswire.comBioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024May 1, 2024 | finance.yahoo.comBioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesMay 1, 2024 | globenewswire.comBioCardia's CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesApril 25, 2024 | globenewswire.comBioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortApril 1, 2024 | finance.yahoo.comBioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finanznachrichten.deBioCardia, Inc.: BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsMarch 29, 2024 | finance.yahoo.comBioCardia Full Year 2023 Earnings: Misses ExpectationsMarch 28, 2024 | benzinga.comPreview: BioCardia's EarningsMarch 28, 2024 | markets.businessinsider.comBioCardia is about to announce its earnings — here's what to expectMarch 28, 2024 | finance.yahoo.comQ4 2023 BioCardia Inc Earnings CallMarch 27, 2024 | benzinga.comBioCardia: Q4 Earnings InsightsMarch 27, 2024 | globenewswire.comBioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsMarch 20, 2024 | money.usnews.comBioCardia Inc.March 20, 2024 | globenewswire.comBioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024March 13, 2024 | finanznachrichten.deBioCardia, Inc.: BioCardia and StemCardia Announce Biotherapeutic Delivery PartnershipMarch 13, 2024 | globenewswire.comBioCardia and StemCardia Announce Biotherapeutic Delivery PartnershipMarch 12, 2024 | finanznachrichten.deBioCardia, Inc.: BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyMarch 12, 2024 | msn.comBioCardia spikes after Medicare coverage for cell therapy trialMarch 12, 2024 | globenewswire.comBioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyMarch 4, 2024 | markets.businessinsider.comBioCardia Reports Positive Interim Results From Phase III CardiAMP Cell Therapy Heart Failure TrialMarch 4, 2024 | globenewswire.comBioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart FailureFebruary 27, 2024 | finance.yahoo.comBCDA Mar 2024 1.500 callFebruary 17, 2024 | finance.yahoo.comBCDA Aug 2024 0.500 callFebruary 17, 2024 | finance.yahoo.comBCDA Mar 2024 0.500 callFebruary 10, 2024 | msn.comBioCardia Inc Secures Funding Through Private PlacementFebruary 10, 2024 | msn.comBioCardia Inc Conducts Unregistered Equity Securities SaleFebruary 9, 2024 | msn.comBioCardia Launches Pivotal CardiAMP HF II TrialFebruary 8, 2024 | finanznachrichten.deBioCardia, Inc.: BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDAFebruary 8, 2024 | finance.yahoo.comBioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDAFebruary 1, 2024 | msn.comBioCardia to Present CardiAMP and CardiALLO at ConferenceJanuary 31, 2024 | finance.yahoo.comBioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics ConferenceJanuary 3, 2024 | finance.yahoo.comBioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for ShareholdersJanuary 1, 2024 | finance.yahoo.comPositive Signs As Multiple Insiders Buy BioCardia StockDecember 22, 2023 | benzinga.comBioCardia Stock (NASDAQ:BCDA) Dividends: History, Yield and DatesDecember 19, 2023 | finance.yahoo.comBioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection FractionDecember 18, 2023 | finance.yahoo.comBioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation MinutesNovember 29, 2023 | finance.yahoo.comBioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product ApprovalNovember 16, 2023 | finance.yahoo.comBioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq RulesNovember 15, 2023 | msn.comBioCardia (BCDA) Soars 168% on FDA Nod to Heart Failure Study Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address NEW AI developed by trader who won 1,129% (in 2 days) (Ad)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans... Click here to see how >>> BCDA Media Mentions By Week BCDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCDA News Sentiment▼0.720.62▲Average Medical News Sentiment BCDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCDA Articles This Week▼41▲BCDA Articles Average Week Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: JAN News CARA News VBIV News UNCY News KPRX News IMNN News CDIO News RDHL News PHXM News ATHE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCDA) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
